← All organizations
Highest phase reached
Phase 4
First clinical trial
May 31, 2013Last known activity
Dec 8, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT04680923Reponsible party - principal investigatorN/ADec 8, 2020
- NCT04680923Overall official - principal investigatorN/ADec 8, 2020
- NCT04680923Lead sponsorN/ADec 8, 2020
- NCT05588518Lead sponsorN/AApr 1, 2019
- NCT05588518Overall official - principal investigatorN/AApr 1, 2019
- NCT05588518Reponsible party - principal investigatorN/AApr 1, 2019
- NCT01887483Overall official - principal investigatorPhase 4Mar 1, 2014
- NCT04673500Reponsible party - principal investigatorN/AMay 31, 2013
- NCT04673500Overall official - principal investigatorN/AMay 31, 2013
- NCT04673500Lead sponsorN/AMay 31, 2013
Details
- Last known activity
- Dec 8, 2020